Does A Procter & Gamble-Aventis Merger Make Cents?
This article was originally published in The Tan Sheet
Executive Summary
A combination between Procter & Gamble and France's largest drug maker, Aventis, would give P&G an immediate play into the prescription drug arena while simultaneously bolstering the firm's Rx-to-OTC switch pipeline with potential blockbuster candidates
You may also be interested in...
P&G Gains European OTC Allergy Presence With Grupo Vita Acquisition
Procter & Gamble's purchase of Spanish pharmaceutical company Grupo Vita's commercial business gives the firm access to the non-sedating antihistamine loratadine
P&G Gains European OTC Allergy Presence With Grupo Vita Acquisition
Procter & Gamble's purchase of Spanish pharmaceutical company Grupo Vita's commercial business gives the firm access to the non-sedating antihistamine loratadine
P&G Gains European OTC Allergy Presence With Grupo Vita Acquisition
Procter & Gamble's purchase of Spanish pharmaceutical company Grupo Vita's commercial business gives the firm access to the non-sedating antihistamine loratadine